Stock Rich List
#3486 on the rich list of 14,644 insiders

David P. Meeker

President and CEO at Rhythm Pharmaceuticals; Director at Trevi Therapeutics; Director at Pharvaris. Based in Boston, Massachusetts.

$33.0M
in disclosed stock, −$458K (−1.37%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
3486th of 14,644
Companies held
3
Largest holding
RYTM, 84.6% of total
Latest SEC filing
Sep 14, 2026
Listed but not counted
$2.1M

What the $33.0M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Rhythm Pharmaceuticals RYTM
Common Stock
Directly239,258$116.80$27.9M84.6%Form 4, Sep 14, 2026
Trevi Therapeutics TRVI
Common Stock
Directly352,489$13.72$4.8M14.6%Form 4, Aug 27, 2024
Kardigan KARD
Common Stock
Directly20,706$12.52$259K0.8%Form 4, Jun 17, 2026

Share counts are the amounts David P. Meeker reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on David P. Meeker's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Pharvaris PHVS
Common Stock
Directly
Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio
65,167$31.66$2.1M—Form 3, Mar 18, 2026

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 14, 2026SoldRYTM2,300$105.19$242KView
Sep 14, 2026SoldRYTM6,439$101.75$655KView
Sep 14, 2026SoldRYTM30,746$102.35$3.1MView
Sep 14, 2026SoldRYTM8,698$103.43$900KView
Sep 14, 2026SoldRYTM1,817$104.55$190KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
3483Alison A. Rankin
Insider, Hamilton Beach Brands Holding. Mayfield Heights, OH
$33.1M−$590K (−1.75%)
3484Satish Dhanasekaran
President and CEO, Keysight Technologies. Santa Rosa, CA
$33.1M−$582K (−1.73%)
3485Jeremy Sg Fowden
Director, Primo Brands. Tampa, FL
$33.1M+$387K (+1.18%)
3486David P. Meeker
President and CEO, Rhythm Pharmaceuticals. Boston, MA
$33.0M−$458K (−1.37%)
3487Josh D. Paul
Chief Accounting Officer, Palo Alto Networks. Santa Clara, CA
$33.0M+$2.0M (+6.42%)
3488Timothy Go
CEO and President, HF Sinclair. Dallas, TX
$33.0M−$340K (−1.02%)
3489Chung-Yao Yin
Director, Gogoro
$33.0M−$1.8M (−5.23%)

Other Rhythm Pharmaceuticals insiders

All RYTM insiders

Questions

How much stock does David P. Meeker own?

David P. Meeker holds $33,040,723 in listed stock based on SEC filings and current prices, mostly Rhythm Pharmaceuticals (RYTM). That ranks 3486th on the Stock Rich List.

Is this David P. Meeker's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did David P. Meeker last buy or sell stock?

The most recent open-market trade on file is a sale of 2,300 RYTM shares on Sep 14, 2026 at $105.19.